DT TKA: RELIABILITY AND VALIDITY OF THE DT BALANCE TEST IN PATIENTS WITH TKA
Sponsor
Dokuz Eylul University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06108466
Collaborator
(none)
31
1
22.3
1.4
Study Details
Study Description
Brief Summary
The ability to perform a cognitive task while walking simultaneously is essential in real daily life. However, the psychometric properties of dual-task walking tests have not been well established in patients undergoing total knee arthroplasty (TKA). The aim of study assess the test-retest reliability and validity of dual conditions TUG, 3MBWT, 8FWT nad 4SST in patients with TKA.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
31 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
RELIABILITY AND VALIDITY OF THE DUAL TASK BALANCE TEST IN PATIENTS WITH TOTAL KNEE ARTHROPLASTY
Actual Study Start Date
:
Jan 14, 2022
Anticipated Primary Completion Date
:
Nov 12, 2023
Anticipated Study Completion Date
:
Nov 25, 2023
Outcome Measures
Primary Outcome Measures
- Performance test [1 Hour]
Timed Up and Go Test
- Performance Test [1 hour]
3MWT
- Perfromance Test [1 hour]
8 FWT
- Performance Test [1 hour]
4SST
Other Outcome Measures
- Patient Reported [1 hour]
HSS Knee Score
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria: TKA -
Exclusion Criteria: revision knee arthroplasty
-
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dokuz Eylul University | İzmir | Turkey |
Sponsors and Collaborators
- Dokuz Eylul University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Damla Ozcan,
Msc. Pt,
Dokuz Eylul University
ClinicalTrials.gov Identifier:
NCT06108466
Other Study ID Numbers:
- 6749-GOA
First Posted:
Oct 31, 2023
Last Update Posted:
Oct 31, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Damla Ozcan,
Msc. Pt,
Dokuz Eylul University
Additional relevant MeSH terms: